What is the management for an adult patient with a non-functioning adrenal adenoma that has grown from 2.5 cm to 3.5 cm over 8 years?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Non-Functioning Adrenal Adenoma with 1 cm Growth Over 8 Years

Direct Recommendation

This adenoma requires repeat imaging in 6-12 months but does NOT meet criteria for surgical intervention, as the growth rate of 1.25 mm/year is well below the 5 mm/year threshold that would warrant adrenalectomy. 1

Growth Rate Analysis

The critical decision point hinges on annual growth rate calculation:

  • Your adenoma grew 10 mm over 8 years = 1.25 mm/year
  • The 2023 CUA/AUA guidelines explicitly state that adrenalectomy should only be considered for growth >5 mm/year 1
  • Growth <3 mm/year requires no further imaging follow-up or functional testing 1
  • Your growth rate falls in the intermediate zone (between 3-5 mm/year), warranting continued surveillance 2

Required Confirmatory Steps Before Proceeding

1. Verify Benign Imaging Characteristics

You must confirm this is truly a benign adenoma by checking:

  • Unenhanced CT attenuation ≤10 Hounsfield Units (HU) - this is diagnostic of benign lipid-rich adenoma 2, 3
  • If attenuation is >10 HU, perform either contrast washout CT (>60% washout at 15 minutes indicates benign) or chemical shift MRI 1, 2
  • Ensure the mass is homogeneous with well-defined margins 4, 3

2. Repeat Functional Testing

Even though initially non-functioning, you must repeat hormonal evaluation now because autonomous hormone secretion can develop over time:

  • 1 mg overnight dexamethasone suppression test (cortisol should be ≤50 nmol/L or ≤1.8 µg/dL) 3
  • Plasma-free metanephrines or 24-hour urinary metanephrines to exclude pheochromocytoma 1, 4
  • Plasma aldosterone and renin activity to exclude hyperaldosteronism 1, 4

This repeat testing is critical because mild autonomous cortisol secretion (MACS) occurs in a significant proportion of incidentalomas and carries increased morbidity/mortality risk 3.

Surveillance Strategy

Obtain repeat imaging in 6-12 months 1, 2:

  • If growth remains <3 mm on this follow-up scan, discontinue all surveillance - no further imaging or functional testing required 1
  • If growth accelerates to >5 mm/year on follow-up, then consider adrenalectomy after repeating functional workup 1

Size Considerations

Your adenoma is now 3.5 cm, which is relevant:

  • Adenomas <4 cm with confirmed benign characteristics and no hormonal activity do not require surgery based on size alone 1, 4
  • The traditional 4 cm cutoff for increased malignancy risk does not apply when imaging clearly demonstrates benign features (≤10 HU) 1, 3
  • Homogeneous lesions with HU ≤10 are benign regardless of size 3

Critical Pitfalls to Avoid

  • Do not operate based on growth alone - the 1.25 mm/year rate is far below surgical thresholds and likely represents measurement variability 1
  • Do not skip repeat hormonal testing - assuming continued non-function without verification can miss developing MACS 3
  • Do not use the older 3 cm surgical threshold - outdated 1989 data suggested surgery for all tumors >3 cm 5, but modern imaging allows confident identification of benign lesions that can be safely observed 3

When Surgery Would Be Indicated

Adrenalectomy would only be appropriate if:

  • Growth accelerates to >5 mm/year on subsequent imaging 1
  • Repeat functional testing reveals new hormone hypersecretion 1, 3
  • Imaging characteristics change to suggest malignancy (irregular margins, heterogeneity, HU >20) 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Benign Adrenal Adenoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Small Adrenal Adenomas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.